Ultragenic Research And Technologies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 2.87 M
as on 03-07-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 03-07-2024
- Revenue 38.23%
(FY 2023)
- Profit 45.94%
(FY 2023)
- Ebitda 3.67%
(FY 2023)
- Net Worth 160.95%
(FY 2023)
- Total Assets 88.11%
(FY 2023)
About Ultragenic Research And Technologies
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.87 M.
The company currently has active open charges totaling ₹2.00 M.
Pravin Nath and Amit Jain serve as directors at the Company.
- CIN/LLPIN
U72900DL2019PTC357694
- Company No.
357694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2019
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ultragenic Research And Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Nath  | Director | 27-Jul-2020 | Current |
| Amit Jain | Director | 19-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Ultragenic Research And Technologies.
Ultragenic Research And Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.23% increase. The company also saw a substantial improvement in profitability, with a 45.94% increase in profit. The company's net worth Soared by an impressive increase of 160.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultragenic Research And Technologies?
In 2023, Ultragenic Research And Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Jul 2021 | ₹2.00 M | Open |
How Many Employees Work at Ultragenic Research And Technologies?
Ultragenic Research And Technologies has a workforce of 132 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultragenic Research And Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultragenic Research And Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
